Type |
Details |
Score |
Protein Domain |
Type: |
Family |
Description: |
SPARC (also known as BM-40 or osteonectin) is a matricellular protein essential for embryo development in invertebrates and highly expressed in bone []. It participates in normal tissue remodeling as it regulates the deposition of extracellular matrix, as well as in neoplastic transformation []. It is involved in extracellular matrix (ECM) assembly and fibrosis through binding both fibrillar collagen and basal lamina collagen IV []. It regulates the activity of matrix metalloproteinases (MMPs), as well as the growth factor signaling mediated by cell surface receptors including vascular endothelial growth factor (VEGF) receptor, basic fibroblast growth factor (bFGF), and transforming growth factor (TGF) beta1. Overexpression of SPARC has been linked to cancers []. SPARC is also a bone-associated protein that has a major role in bone development and mineralisation. It is involved in the initiation and progression of vascular calcification and upregulated by adiponectin []. Furthermore, SPARC may be one of the molecules that govern the uptake and delivery of proteins from blood to the cerebrospinal fluid (CSF) during brain development [].SPARC contains an N-terminal acidic 52-residue segment followed by a follistatin-like (FS) domain, and an α-helical EC domain with 2 unusual calcium-binding EF-hands and the collagen-binding site []. Platelet-derived growth factor (PDGF) interacts with its EC domain, but in a calcium-independent manner, whereas collagen binding is calcium-dependent [, , ]. |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
horse |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
172
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
302
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
302
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
302
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
301
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
332
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Kapinas K |
Year: |
2012 |
Journal: |
Matrix Biol |
Title: |
Bone matrix osteonectin limits prostate cancer cell growth and survival. |
Volume: |
31 |
Issue: |
5 |
Pages: |
299-307 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hohenester E |
Year: |
1997 |
Journal: |
EMBO J |
Title: |
Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40. |
Volume: |
16 |
Issue: |
13 |
Pages: |
3778-86 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hohenester E |
Year: |
2008 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Structural basis of sequence-specific collagen recognition by SPARC. |
Volume: |
105 |
Issue: |
47 |
Pages: |
18273-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Botti G |
Year: |
2014 |
Journal: |
Virchows Arch |
Title: |
SPARC/osteonectin is involved in metastatic process to the lung during melanoma progression. |
Volume: |
465 |
Issue: |
3 |
Pages: |
331-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Niknam S |
Year: |
2015 |
Journal: |
Int J Mol Cell Med |
Title: |
The effect of adiponectin on osteonectin gene expression by oxidized low density lipoprotein-treated vascular smooth muscle cells. |
Volume: |
4 |
Issue: |
1 |
Pages: |
60-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liddelow SA |
Year: |
2011 |
Journal: |
Eur J Neurosci |
Title: |
SPARC/osteonectin, an endogenous mechanism for targeting albumin to the blood-cerebrospinal fluid interface during brain development. |
Volume: |
34 |
Issue: |
7 |
Pages: |
1062-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maurer P |
Year: |
1995 |
Journal: |
J Mol Biol |
Title: |
The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV. |
Volume: |
253 |
Issue: |
2 |
Pages: |
347-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kelm RJ Jr |
Year: |
1990 |
Journal: |
Blood |
Title: |
Human platelet osteonectin: release, surface expression, and partial characterization. |
Volume: |
75 |
Issue: |
5 |
Pages: |
1105-13 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7311967 |
Assay Type: |
RNA in situ |
Annotation Date: |
2023-09-25 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1736422 |
Pattern: |
Not Specified |
Stage: |
TS22 |
Assay Id: |
MGI:7530041 |
Age: |
embryonic day 14.5 |
Image: |
4b Sparc E14.5 |
Note: |
Expression in mature functional osteoblasts. Expression throughout developing palatal mesenchyme. |
Specimen Label: |
4b Sparc E14.5 |
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7311967 |
Assay Type: |
RNA in situ |
Annotation Date: |
2023-09-25 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1736422 |
Pattern: |
Not Specified |
Stage: |
TS22 |
Assay Id: |
MGI:7530041 |
Age: |
embryonic day 14.5 |
Image: |
4a Sparc E14.5 |
Note: |
Expression in mature functional osteoblasts. Expression throughout developing palatal mesenchyme. |
Specimen Label: |
4a Sparc E14.5 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7311967 |
Assay Type: |
RNA in situ |
Annotation Date: |
2023-09-25 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1736423 |
Pattern: |
Not Specified |
Stage: |
TS23 |
Assay Id: |
MGI:7530041 |
Age: |
embryonic day 15.5 |
Image: |
4a Sparc E15.5 |
Note: |
Expression in mature functional osteoblasts. Expression throughout developing palatal mesenchyme. |
Specimen Label: |
4a Sparc E15.5 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7311967 |
Assay Type: |
RNA in situ |
Annotation Date: |
2023-09-25 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1736423 |
Pattern: |
Regionally restricted |
Stage: |
TS23 |
Assay Id: |
MGI:7530041 |
Age: |
embryonic day 15.5 |
Image: |
4b Sparc E15.5 |
Note: |
Expression in mature functional osteoblasts. Expression throughout developing palatal mesenchyme. Diffuse expression in central ossification centers. |
Specimen Label: |
4b Sparc E15.5 |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mason IJ |
Year: |
1986 |
Journal: |
EMBO J |
Title: |
Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell 'culture shock' glycoprotein of Mr 43,000. |
Volume: |
5 |
Issue: |
7 |
Pages: |
1465-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sasaki T |
Year: |
1998 |
Journal: |
EMBO J |
Title: |
Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin. |
Volume: |
17 |
Issue: |
6 |
Pages: |
1625-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
McVey JH |
Year: |
1988 |
Journal: |
J Biol Chem |
Title: |
Characterization of the mouse SPARC/osteonectin gene. Intron/exon organization and an unusual promoter region. |
Volume: |
263 |
Issue: |
23 |
Pages: |
11111-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Engel J |
Year: |
1987 |
Journal: |
Biochemistry |
Title: |
Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues. |
Volume: |
26 |
Issue: |
22 |
Pages: |
6958-65 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Publication |
First Author: |
Campolongo M |
Year: |
2012 |
Journal: |
Genes Brain Behav |
Title: |
Hippocampal SPARC regulates depression-related behavior. |
Volume: |
11 |
Issue: |
8 |
Pages: |
966-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Norose K |
Year: |
1998 |
Journal: |
Invest Ophthalmol Vis Sci |
Title: |
SPARC deficiency leads to early-onset cataractogenesis. |
Volume: |
39 |
Issue: |
13 |
Pages: |
2674-80 |
|
•
•
•
•
•
|
UniProt Feature |
Begin: |
18 |
Description: |
SPARC |
Type: |
chain |
End: |
302 |
|
•
•
•
•
•
|
UniProt Feature |
Begin: |
18 |
Description: |
SPARC |
Type: |
chain |
End: |
302 |
|
•
•
•
•
•
|
UniProt Feature |
Begin: |
18 |
Description: |
SPARC |
Type: |
chain |
End: |
301 |
|
•
•
•
•
•
|
UniProt Feature |
Begin: |
18 |
Description: |
SPARC |
Type: |
chain |
End: |
172 |
|
•
•
•
•
•
|
UniProt Feature |
Begin: |
18 |
Description: |
SPARC |
Type: |
chain |
End: |
302 |
|
•
•
•
•
•
|
UniProt Feature |
Begin: |
48 |
Description: |
SPARC |
Type: |
chain |
End: |
332 |
|
•
•
•
•
•
|
Publication |
First Author: |
Albrecht D |
Year: |
2012 |
Journal: |
Mol Cell Neurosci |
Title: |
SPARC prevents maturation of cholinergic presynaptic terminals. |
Volume: |
49 |
Issue: |
3 |
Pages: |
364-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luo Z |
Year: |
2012 |
Journal: |
Exp Hematol |
Title: |
SPARC promotes the development of erythroid progenitors. |
Volume: |
40 |
Issue: |
10 |
Pages: |
828-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sansom OJ |
Year: |
2007 |
Journal: |
Gut |
Title: |
Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice. |
Volume: |
56 |
Issue: |
10 |
Pages: |
1410-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sangaletti S |
Year: |
2011 |
Journal: |
Am J Pathol |
Title: |
SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage. |
Volume: |
179 |
Issue: |
6 |
Pages: |
3000-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stary M |
Year: |
2005 |
Journal: |
Exp Cell Res |
Title: |
Parietal endoderm secreted SPARC promotes early cardiomyogenesis in vitro. |
Volume: |
310 |
Issue: |
2 |
Pages: |
331-43 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sangaletti S |
Year: |
2008 |
Journal: |
Cancer Res |
Title: |
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. |
Volume: |
68 |
Issue: |
21 |
Pages: |
9050-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Greiling TM |
Year: |
2009 |
Journal: |
Exp Eye Res |
Title: |
Absence of SPARC leads to impaired lens circulation. |
Volume: |
89 |
Issue: |
3 |
Pages: |
416-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kelly KA |
Year: |
2007 |
Journal: |
J Leukoc Biol |
Title: |
SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration. |
Volume: |
81 |
Issue: |
3 |
Pages: |
748-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Said N |
Year: |
2013 |
Journal: |
J Clin Invest |
Title: |
Loss of SPARC in bladder cancer enhances carcinogenesis and progression. |
Volume: |
123 |
Issue: |
2 |
Pages: |
751-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sussman AN |
Year: |
2009 |
Journal: |
Am J Pathol |
Title: |
SPARC accelerates disease progression in experimental crescentic glomerulonephritis. |
Volume: |
174 |
Issue: |
5 |
Pages: |
1827-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Deckx S |
Year: |
2019 |
Journal: |
PLoS One |
Title: |
Extracellular SPARC increases cardiomyocyte contraction during health and disease. |
Volume: |
14 |
Issue: |
4 |
Pages: |
e0209534 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rivera LB |
Year: |
2011 |
Journal: |
J Cell Biol |
Title: |
SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity. |
Volume: |
193 |
Issue: |
7 |
Pages: |
1305-19 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shubham K |
Year: |
2012 |
Journal: |
Mol Vis |
Title: |
Pax6 interacts with SPARC and TGF-β in murine eyes. |
Volume: |
18 |
|
Pages: |
951-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lloyd-Burton SM |
Year: |
2013 |
Journal: |
J Neurosci |
Title: |
SPARC regulates microgliosis and functional recovery following cortical ischemia. |
Volume: |
33 |
Issue: |
10 |
Pages: |
4468-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Song H |
Year: |
2010 |
Journal: |
Biochem Biophys Res Commun |
Title: |
SPARC interacts with AMPK and regulates GLUT4 expression. |
Volume: |
396 |
Issue: |
4 |
Pages: |
961-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nie J |
Year: |
2009 |
Journal: |
J Biol Chem |
Title: |
SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. |
Volume: |
284 |
Issue: |
2 |
Pages: |
1279-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Harris BS |
Year: |
2011 |
Journal: |
Am J Physiol Heart Circ Physiol |
Title: |
SPARC regulates collagen interaction with cardiac fibroblast cell surfaces. |
Volume: |
301 |
Issue: |
3 |
Pages: |
H841-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
McCurdy SM |
Year: |
2011 |
Journal: |
Am J Physiol Heart Circ Physiol |
Title: |
SPARC mediates early extracellular matrix remodeling following myocardial infarction. |
Volume: |
301 |
Issue: |
2 |
Pages: |
H497-505 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jørgensen LH |
Year: |
2017 |
Journal: |
Am J Pathol |
Title: |
SPARC Interacts with Actin in Skeletal Muscle in Vitro and in Vivo. |
Volume: |
187 |
Issue: |
2 |
Pages: |
457-474 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tseng C |
Year: |
2016 |
Journal: |
Stem Cells |
Title: |
Proteolytic Isoforms of SPARC Induce Adipose Stromal Cell Mobilization in Obesity. |
Volume: |
34 |
Issue: |
1 |
Pages: |
174-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mason IJ |
Year: |
1986 |
Journal: |
EMBO J |
Title: |
Developmental and transformation-sensitive expression of the Sparc gene on mouse chromosome 11. |
Volume: |
5 |
Issue: |
8 |
Pages: |
1831-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Said N |
Year: |
2009 |
Journal: |
Oncogene |
Title: |
The role of SPARC in the TRAMP model of prostate carcinogenesis and progression. |
Volume: |
28 |
Issue: |
39 |
Pages: |
3487-98 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ryu S |
Year: |
2023 |
Journal: |
J Clin Invest |
Title: |
Reduction of SPARC protects mice against NLRP3 inflammasome activation and obesity. |
Volume: |
133 |
Issue: |
19 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Sangaletti S |
Year: |
2019 |
Journal: |
Front Immunol |
Title: |
SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities. |
Volume: |
10 |
|
Pages: |
1369 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang DY |
Year: |
2008 |
Journal: |
J Pathol |
Title: |
Transcription factor SOX-5 enhances nasopharyngeal carcinoma progression by down-regulating SPARC gene expression. |
Volume: |
214 |
Issue: |
4 |
Pages: |
445-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ryu S |
Year: |
2022 |
Journal: |
Immunity |
Title: |
The matricellular protein SPARC induces inflammatory interferon-response in macrophages during aging. |
Volume: |
55 |
Issue: |
9 |
Pages: |
1609-1626.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu L |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic β cells. |
Volume: |
10 |
Issue: |
1 |
Pages: |
17581 |
|
•
•
•
•
•
|
Publication |
First Author: |
Holland PW |
Year: |
1987 |
Journal: |
J Cell Biol |
Title: |
In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization. |
Volume: |
105 |
Issue: |
1 |
Pages: |
473-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tichet M |
Year: |
2015 |
Journal: |
Nat Commun |
Title: |
Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis. |
Volume: |
6 |
|
Pages: |
6993 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6184086 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689419 |
Pattern: |
Not Specified |
Stage: |
TS19 |
Assay Id: |
MGI:6191376 |
Age: |
embryonic day 11.5 |
|
|
Specimen Label: |
Table S2 - E11.5 - Sparc |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6184086 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689421 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:6191376 |
Age: |
embryonic day 13.5 |
|
|
Specimen Label: |
Table S2 - E13.5 - Sparc |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6184086 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689424 |
Pattern: |
Not Specified |
Stage: |
TS24 |
Assay Id: |
MGI:6191376 |
Age: |
embryonic day 15.5 |
|
|
Specimen Label: |
Table S2 - E15.5 - Sparc |
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6184086 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689426 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:6191376 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
Table S2 - E18.5 - Sparc |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6184086 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6191376 |
Age: |
postnatal day 4 |
|
|
Specimen Label: |
Table S2 - P4 - Sparc |
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6184086 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6191376 |
Age: |
postnatal day 14 |
|
|
Specimen Label: |
Table S2 - P14 - Sparc |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6184086 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6191376 |
Age: |
postnatal day 28 |
|
|
Specimen Label: |
Table S2 - P28 - Sparc |
Detected: |
true |
Specimen Num: |
7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wong SY |
Year: |
2008 |
Journal: |
Clin Exp Metastasis |
Title: |
Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer. |
Volume: |
25 |
Issue: |
2 |
Pages: |
109-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Basu A |
Year: |
2001 |
Journal: |
BMC Cell Biol |
Title: |
Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40). |
Volume: |
2 |
|
Pages: |
15 |
|
•
•
•
•
•
|
Publication |
First Author: |
de Castro Brás LE |
Year: |
2014 |
Journal: |
Biomed Res Int |
Title: |
Age and SPARC change the extracellular matrix composition of the left ventricle. |
Volume: |
2014 |
|
Pages: |
810562 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yan Q |
Year: |
2005 |
Journal: |
Invest Ophthalmol Vis Sci |
Title: |
Absence of SPARC in murine lens epithelium leads to increased deposition of laminin-1 in lens capsule. |
Volume: |
46 |
Issue: |
12 |
Pages: |
4652-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ehninger A |
Year: |
2014 |
Journal: |
Blood |
Title: |
Loss of SPARC protects hematopoietic stem cells from chemotherapy toxicity by accelerating their return to quiescence. |
Volume: |
123 |
Issue: |
26 |
Pages: |
4054-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rentz TJ |
Year: |
2007 |
Journal: |
J Biol Chem |
Title: |
SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts. |
Volume: |
282 |
Issue: |
30 |
Pages: |
22062-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Riley HJ |
Year: |
2021 |
Journal: |
Am J Physiol Heart Circ Physiol |
Title: |
SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overload. |
Volume: |
320 |
Issue: |
2 |
Pages: |
H604-H612 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luo Z |
Year: |
2014 |
Journal: |
J Leukoc Biol |
Title: |
SPARC deficiency affects bone marrow stromal function, resulting in impaired B lymphopoiesis. |
Volume: |
96 |
Issue: |
1 |
Pages: |
73-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Francki A |
Year: |
1999 |
Journal: |
J Biol Chem |
Title: |
SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells. |
Volume: |
274 |
Issue: |
45 |
Pages: |
32145-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gruber HE |
Year: |
2005 |
Journal: |
J Histochem Cytochem |
Title: |
Targeted deletion of the SPARC gene accelerates disc degeneration in the aging mouse. |
Volume: |
53 |
Issue: |
9 |
Pages: |
1131-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Arai M |
Year: |
2024 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Effect of Sparc knockout on the extracellular matrix of mouse periodontal ligament cells. |
Volume: |
692 |
|
Pages: |
149364 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brekken RA |
Year: |
2003 |
Journal: |
J Clin Invest |
Title: |
Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. |
Volume: |
111 |
Issue: |
4 |
Pages: |
487-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mazzolini G |
Year: |
2018 |
Journal: |
Sci Rep |
Title: |
SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease. |
Volume: |
8 |
Issue: |
1 |
Pages: |
725 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schellings MW |
Year: |
2009 |
Journal: |
J Exp Med |
Title: |
Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. |
Volume: |
206 |
Issue: |
1 |
Pages: |
113-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rienks M |
Year: |
2018 |
Journal: |
Matrix Biol |
Title: |
SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis. |
Volume: |
74 |
|
Pages: |
21-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lankat-Buttgereit B |
Year: |
1988 |
Journal: |
FEBS Lett |
Title: |
Cloning and complete amino acid sequences of human and murine basement membrane protein BM-40 (SPARC, osteonectin). |
Volume: |
236 |
Issue: |
2 |
Pages: |
352-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mann K |
Year: |
1987 |
Journal: |
FEBS Lett |
Title: |
Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC. |
Volume: |
218 |
Issue: |
1 |
Pages: |
167-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Enriquez C |
Year: |
2021 |
Journal: |
Cancer Res |
Title: |
Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer. |
Volume: |
81 |
Issue: |
16 |
Pages: |
4257-4274 |
|
•
•
•
•
•
|
Publication |
First Author: |
Seet LF |
Year: |
2010 |
Journal: |
PLoS One |
Title: |
SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery. |
Volume: |
5 |
Issue: |
2 |
Pages: |
e9415 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brayman VL |
Year: |
2021 |
Journal: |
Neurosci Lett |
Title: |
Roles of the synaptic molecules Hevin and SPARC in mouse neuromuscular junction development and repair. |
Volume: |
746 |
|
Pages: |
135663 |
|
•
•
•
•
•
|